The TMA assay has shown that 94 of the 214 GCA tumors (44%) were strongly stained with anti-CYR61, and 120 tumor samples (56%) had weak or no staining (Figure 1B), indicating that CYR61 is overexpressed in GCA with a high frequency. This evidence concerns the gene CCN1 and temporal arteritis.